华润医药(03320.HK) 公布,集团旗下华润双鹤所属业务单元神舟生物,于合成生物产业化应用领域迎来重要突破,核心生物基产品1,4 - 丁二胺已成功导入下游合作伙伴沃特股份全新发布的Wouper PA46 生物基高性能聚酰胺材料体系,标志集团相关产品正式进入高性能材料终端应用领域。沃特股份推出之Wouper PA46,定位为生物基高性能聚酰胺标杆产品。该材料融合生物基原料的绿色属性与高性能...
Source Link华润医药(03320.HK) 公布,集团旗下华润双鹤所属业务单元神舟生物,于合成生物产业化应用领域迎来重要突破,核心生物基产品1,4 - 丁二胺已成功导入下游合作伙伴沃特股份全新发布的Wouper PA46 生物基高性能聚酰胺材料体系,标志集团相关产品正式进入高性能材料终端应用领域。沃特股份推出之Wouper PA46,定位为生物基高性能聚酰胺标杆产品。该材料融合生物基原料的绿色属性与高性能...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.